Page 156 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 156
Cirrhosis and its Complications: Bleeding, Hepatorenal Syndrome and Ascites (Cont.)
P0204 NONINVASIVE PREDICTION OF HEMODYNAMIC
RESPONSE TO BETA-BLOCKER THERAPY IN CIRRHOTIC
PATIENTS WITH ESOPHAGEAL VARICES
Hwi Young Kim*, Won Kim,Yong Jin Jung, Sae Kyung Joo,Young Ho So,
Hyunsik Woo, South Korea
P0205 MANAGEMENT OF GASTRIC VARICES: A FRENCH
NATIONAL SURVEY
Delphine Weil*, Jean Paul Cervoni, Nadim Fares, Marika Rudler,
Christophe Bureau, Aurélie Plessier, Thong Dao, Arnaud Pauwels,
Dominique Thabut, Paul Castellani, Frédéric Oberti, Nicolas Carbonell,
Vincent Di Martino, Thierry Thévenot, France
P0206 PREVENTION OF BLEEDING FOLLOWING INVASIVE
PROCEDURES IN CIRRHOTIC PATIENTS: A SINGLE
CENTER EXPERIENCE
Federica Invernizzi*, Giulia Tosetti, Vincenzo La Mura, Alessio Aghemo,
Massimo Primignani, Angelo Sanvgiovanni, Maria Francesca Donato,
Antonio Nicolini, Massimo Iavarone, Massimo Colombo, Italy
ePOSTERS P0207 GUANFACINE (SPECIFIC ALPHA-2A ADRENOCEPTOR
AGONIST) RESTORES NATRIURESIS IN EXPERIMENTAL
CIRRHOTIC ASCITES RESISTANT TO CLONIDINE AND
STANDARD DIURETICS
Giovanni Sansoe*, Manuela Aragno, Raffaella Mastrocola,
Maurizio Parola, Italy
YI P0208 HEMODYNAMIC RESPONSETO NON-SELECTIVE BETA-
BLOCKERS IS NOT INFLUENCED BYTHE PRESENCE OF
METABOLIC SYNDROME
Simona Bota*, Philipp Schwabl, Mattias Mandorfer, Petra Salzl,
Remy Schwarzer, Arnulf Ferlitsch, Michael Trauner, Markus Peck-
Radosavljevic,Thomas Reiberger, Austria
YI P0209 A COMMON POLYMORPHISM OF TUMOR NECROSIS
FACTOR RECEPTOR-ASSOCIATED FACTOR 6 (TRAF6)
IS ASSOCIATED WITH AN INCREASED RISK FOR
SPONTANEOUS BACTERIAL PERITONITIS
Martina Mai*, Sven Stengel, Eihab Al-Herwi, Philipp Reuken,
Andreas Stallmach, Tony Bruns, Germany
156 The International Liver Congress™ 2015 • ILC Programme
P0204 NONINVASIVE PREDICTION OF HEMODYNAMIC
RESPONSE TO BETA-BLOCKER THERAPY IN CIRRHOTIC
PATIENTS WITH ESOPHAGEAL VARICES
Hwi Young Kim*, Won Kim,Yong Jin Jung, Sae Kyung Joo,Young Ho So,
Hyunsik Woo, South Korea
P0205 MANAGEMENT OF GASTRIC VARICES: A FRENCH
NATIONAL SURVEY
Delphine Weil*, Jean Paul Cervoni, Nadim Fares, Marika Rudler,
Christophe Bureau, Aurélie Plessier, Thong Dao, Arnaud Pauwels,
Dominique Thabut, Paul Castellani, Frédéric Oberti, Nicolas Carbonell,
Vincent Di Martino, Thierry Thévenot, France
P0206 PREVENTION OF BLEEDING FOLLOWING INVASIVE
PROCEDURES IN CIRRHOTIC PATIENTS: A SINGLE
CENTER EXPERIENCE
Federica Invernizzi*, Giulia Tosetti, Vincenzo La Mura, Alessio Aghemo,
Massimo Primignani, Angelo Sanvgiovanni, Maria Francesca Donato,
Antonio Nicolini, Massimo Iavarone, Massimo Colombo, Italy
ePOSTERS P0207 GUANFACINE (SPECIFIC ALPHA-2A ADRENOCEPTOR
AGONIST) RESTORES NATRIURESIS IN EXPERIMENTAL
CIRRHOTIC ASCITES RESISTANT TO CLONIDINE AND
STANDARD DIURETICS
Giovanni Sansoe*, Manuela Aragno, Raffaella Mastrocola,
Maurizio Parola, Italy
YI P0208 HEMODYNAMIC RESPONSETO NON-SELECTIVE BETA-
BLOCKERS IS NOT INFLUENCED BYTHE PRESENCE OF
METABOLIC SYNDROME
Simona Bota*, Philipp Schwabl, Mattias Mandorfer, Petra Salzl,
Remy Schwarzer, Arnulf Ferlitsch, Michael Trauner, Markus Peck-
Radosavljevic,Thomas Reiberger, Austria
YI P0209 A COMMON POLYMORPHISM OF TUMOR NECROSIS
FACTOR RECEPTOR-ASSOCIATED FACTOR 6 (TRAF6)
IS ASSOCIATED WITH AN INCREASED RISK FOR
SPONTANEOUS BACTERIAL PERITONITIS
Martina Mai*, Sven Stengel, Eihab Al-Herwi, Philipp Reuken,
Andreas Stallmach, Tony Bruns, Germany
156 The International Liver Congress™ 2015 • ILC Programme
